Skip to contentS
Strata Critical Medical, Inc.
S
SRTAStrata Critical Medical, Inc. Q3 2022 · 10-Q
Revenue$45.72M$45.72M+125.1% vs Q3 2021 Net Income-$9.25M-$9.25MN/M vs Q3 2021 EPS Diluted-$0.13-$0.13N/M vs Q3 2021 The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Strata Critical Medical, Inc. · CIK 1779128 · Engraved from SEC EDGAR
Operating Cash Flowderived-$6,351,000N/M Free Cash Flowderived-$6,444,000N/M Margins · derivedGross margin20.3%
Operating margin-22.8%+25.1 pt vs Q3 2021
Net margin-20.2%+25.0 pt vs Q3 2021
ended Sep 30, 2022 · filed Nov 10, 2022 · 41 d after period end